aspartic acid has been researched along with Leukemia, Lymphocytic, T Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borst, J; de Vries, E; Eldering, E; Tait, SW; Werner, AB | 1 |
1 other study(ies) available for aspartic acid and Leukemia, Lymphocytic, T Cell
| Article | Year |
|---|---|
Requirement for aspartate-cleaved bid in apoptosis signaling by DNA-damaging anti-cancer regimens.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aspartic Acid; BH3 Interacting Domain Death Agonist Protein; Carrier Proteins; Caspase 2; Caspase 8; Caspase 9; Caspases; Cell Line; Cytochromes c; Cytoplasm; DNA Damage; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Etoposide; Flow Cytometry; Gamma Rays; Genes, Dominant; Granzymes; Humans; Immunoblotting; Jurkat Cells; Leukemia, T-Cell; Liver; Mice; Mitochondria; Models, Biological; Mutation; Retroviridae; RNA, Small Interfering; Serine Endopeptidases; Signal Transduction; Tumor Suppressor Protein p53; Up-Regulation | 2004 |